CoChat

Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Successful and sustainable models for HIV pre-exposure prophylaxis (PrEP) delivery in public health systems in Africa are needed. We aimed to evaluate the implementation of PrEP delivery integrated in public HIV care clinics in Kenya. METHODS: As part of Kenya's national PrEP roll-out, we conducted a stepped-wedge cluster-randomised pragmatic trial to catalyse scale-up of PrEP delivery integrated in 25 public HIV care clinics. We selected high-volume clinics in these regions (ie, those with a high number of people living with HIV enrolled in HIV care and treatment). Clinics (each representing a cluster) were stratified by region and randomly assigned to the order in which clinic staff would receive PrEP training and ongoing technical support using numbered opaque balls picked from a bag. There was no masking. PrEP provision was done by clinic staff without additional financial support. Data were abstracted from records of individuals initiating PrEP. The primary outcome was the number of people initiating PrEP per clinic per month comparing intervention to control periods. Other outcomes included PrEP continuation, adherence, and incident HIV infections. This trial is registered with ClinicalTrials.gov, NCT03052010. FINDINGS: After the baseline period, which started in January, 2017, every month two to six HIV care clinics crossed over from control to intervention, until August, 2017, when all clinics were implementing the intervention. Of 4898 individuals initiating PrEP (27 during the control period and 4871 during the intervention period), 2640 (54%) were women, the median age was 31 years (IQR 25-39), and 4092 (84%) reported having a partner living with HIV. The mean monthly number of PrEP initiations per clinic was 0·1 (SD 0·5) before the intervention and 7·5 (2·7) after intervention introduction (rate ratio 23·7, 95% CI 14·2-39·5, p<0·0001). PrEP continuation was 57% at 1 month, 44% at 3 months, and 34% at 6 months, and 12% of those who missed a refill returned later for PrEP re-initiation. Tenofovir diphosphate was detected in 68 (96%) of 71 blood samples collected from a randomly selected subset of participants. Six HIV infections were observed over 2531 person-years of observation (incidence 0·24 cases per 100 person-years), three of which occurred at the first visit after PrEP initiation. INTERPRETATION: We observed high uptake, reasonable continuation with high adherence, frequent PrEP restarts, and low HIV incidence. Integration of PrEP services within public HIV care clinics in Africa is feasible. FUNDING: National Institute of Mental Health and Bill & Melinda Gates Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2214-109x(21)00391-0

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Order of implementation across clinics C=control period. I=implementation period.
Figure 1 Order of implementation across clinics C=control period. I=implementation period.CC BY-NC-ND · PubMed Central
Figure 2 Trial profile PrEP=pre-exposure prophylaxis.
Figure 2 Trial profile PrEP=pre-exposure prophylaxis.CC BY-NC-ND · PubMed Central
Figure 3 PrEP continuation The figure shows the proportion of PrEP users returning (purple), not returning (yellow), and not expected (green) for PrEP refill visits, by month. It also shows individuals with missed previous visits returning for PrEP refills. PrEP=pre-exposure prophylaxis.
Figure 3 PrEP continuation The figure shows the proportion of PrEP users returning (purple), not returning (yellow), and not expected (green) for PrEP refill visits, by month. It also shows individuals with missed previous visits returning for PrEP refills. PrEP=pre-exposure prophylaxis.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 2

  1. Joint United Nations Programme on HIV/AIDS UNAIDS data 2020 2020 Joint United Nations Programme on HIV/AIDS Geneva, Switzerland 12349391
  2. WHO Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015 World Health Organization Geneva 26598776

Cited by

See all 53

Metadata

Authors
Irungu, E. M., Mugwanya, K. K., Mugo, N. R., Bukusi, E. A., Donnell, D., Odoyo, J., Wamoni, E., Peacock, S., Morton, J. F., Ngure, K., Mugambi, M., Mukui, I., O'Malley, G., & Baeten, J. M.
Affiliations
  • University of Washington (US)
  • Kenya Medical Research Institute (KE)
Corresponding author
Irungu, Elizabeth M
Venue
The Lancet Global Health
Publisher
Elsevier BV
Published
2021-12
Volume
9
Issue
12
Pages
e1730-e1739
ISSN
2214-109X (ISSN-L)
OpenAlex
W3212270151
Cited by
49
References
24
Citations by year
2026: 4 · 2025: 13 · 2024: 16 · 2023: 11 · 2022: 4 · 2021: 1
FWCI
2.53
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Global Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (R01MH095507)
  • Bill and Melinda Gates Foundation (OPP10556051)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
Keywords
HIV pre-exposure prophylaxis, PrEP scale-up, PrEP continuation, PrEP adherence, tenofovir diphosphate, HIV prevention, Kenya, people living with HIV, PrEP side effects, PrEP discontinuation
MeSH terms
Tenofovir, Assessment of Medication Adherence, Adult, Ambulatory Care Facilities, Female, Humans, Kenya, Male, HIV Infections, Drug Monitoring, Anti-HIV Agents, Medication Adherence, Pre-Exposure Prophylaxis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. https://app.cochat.ai/papers/10.1016/s2214-109x(21)00391-0
The paper
Irungu, E. M., Mugwanya, K. K., Mugo, N. R., Bukusi, E. A., Donnell, D., Odoyo, J., Wamoni, E., Peacock, S., Morton, J. F., Ngure, K., Mugambi, M., Mukui, I., O'Malley, G., & Baeten, J. M. (2021). Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(21)00391-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.